Dr. Arvind Bakhru, MD, MPH

Dr. Bakhru practices at HonorHealth John C. Lincoln Medical Center in Phoenix, Arizona, part of HonorHealth.

Dr. Bakhru's NPI, 1477689511, was assigned on February 25, 2007. Dr. Bakhru graduated from University of Rochester Medical Center in 2005. Dr. Bakhru holds Arizona license 56650.

Dr. Bakhru's primary practice is HonorHealth John C. Lincoln Medical Center, at 250 East Dunlap Avenue, Phoenix, AZ 85020 in Maricopa County. The practice phone is (602) 943-2381.

Dr. Bakhru's primary practice is HonorHealth John C. Lincoln Medical Center in Phoenix, Arizona, part of HonorHealth. Dr. Bakhru is also affiliated with HonorHealth Deer Valley Medical Center. The medical group on file is HonorHealth Medical Group. Dmand AI also links Dr. Bakhru to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bakhru practices, 7 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Bakhru's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Bakhru is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Bakhru's licenses on file in 6 states: Arizona, Florida, Louisiana, North Carolina, Maryland and Michigan.

Dmand AI lists abdominal adhesion surgery, hysterectomy and ovarian cyst among the conditions Dr. Bakhru treats.

CMS data shows 854 Medicare services from Dr. Bakhru across 12 procedure codes in 2024, for 238 Medicare patients. Medicare paid $101,037 for them.

CMS counts 238 Medicare patients who saw Dr. Bakhru in 2024. The largest group is 65 to 74, with 129 patients. 67% of them have high cholesterol, and 65% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bakhru's median patient age at 64, with 99% women.

In 2024, Dr. Bakhru wrote 1,015 Medicare Part D claims for 210 patients. 81% of them were for generic drugs. CMS names the drug for 770 of them, across 22 drugs with 11 or more claims each, at $1,360,172 in total drug cost. In 2023, CMS named 748 claims across 27 drugs.

Dr. Bakhru accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bakhru as offering telehealth. CMS counts 44 procedures of removal of the uterus by Dr. Bakhru, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Bakhru, published from 2005 to 2013. 2010 was the busiest year, with 3. The most frequent topics are Nutrition Surveys and Ovarian Neoplasms. Dr. Bakhru has published most often in Gynecol Oncol. Dr. Bakhru's most frequent co-authors are Robert O. Atlas, MD, Ronald J. Buckanovich and Thomas Philip Erlinger.

Dmand AI links Dr. Bakhru to 1 clinical trial. Conditions studied include Brenner Tumor and Neoplasms, Fibroepithelial.

CMS Open Payments shows 80 general payments to Dr. Bakhru from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. GlaxoSmithKline, LLC. paid the most, $3,256.

Dr. Bakhru graduated from University of Rochester Medical Center in 2005. Dr. Bakhru is a member of American College of Obstetricians and Gynecologists.

Dr. Bakhru is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.